{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1235.329","meta":{"versionId":"6","lastUpdated":"2023-06-16T01:00:56.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"B.well Connected Health Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-06-16"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-06-16"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1235.329"}],"version":"20230616","name":"HighRiskHPVTest_HD_HCPCS","title":"High Risk HPV Test_HD_HCPCS","status":"active","date":"2023-06-16T01:00:56-04:00","publisher":"B.well Connected Health Steward","description":"b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute High Risk HPV Test for inclusion and utilization in patients/users connected heath.),(Data Element Scope: High Risk HPV Test for b.well.),(Inclusion Criteria: High Risk HPV Test Codes that constitute a Cancer Care Need for b.well.),(Exclusion Criteria: N/A)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"G0476","display":"Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"}]}]},"expansion":{"identifier":"urn:uuid:d1327199-e435-4780-81b5-7282240a097d","timestamp":"2023-12-11T00:28:47-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"G0476","display":"Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"}]}}